Scientist Computational Biology
Bern Area, Switzerland
In November 2010, Vincenzo joined Philip Morris International (PMI), Research and Development, Systems Biology Application and Verification Department, few months before his final PhD examination (February 2011). The research in PMI focused on studying the impact of smoke on both in-vivo and in-vitro biological systems. As Computational Biologist Dr Belcastro first contributed to the development of a web platform hosting diagnostic tools for biological data, and then applied those tools on… Show more In November 2010, Vincenzo joined Philip Morris International (PMI), Research and Development, Systems Biology Application and Verification Department, few months before his final PhD examination (February 2011). The research in PMI focused on studying the impact of smoke on both in-vivo and in-vitro biological systems. As Computational Biologist Dr Belcastro first contributed to the development of a web platform hosting diagnostic tools for biological data, and then applied those tools on time-course gene expression experiments, which eventually resulted in co-authoring a scientific publication.While working at PMI, Dr Belcastro expanded his input to the field of gene network inference by contributing to apply a graph-based gene network model on expression data , and by evaluating and boost the performances of an algorithm to quantify the impact of in-vitro and in-vivo external perturbations on biological systems, for which he was honored of an excellence award. Dr Belcastro has been the major contributor for the evaluation of upstream transcriptional regulators in the context of a cellular proliferation network.Since the very first months, Dr Belcastro was involved in an innovative research project jointly run by PMI and IBM, the Systems Biology Verification (SBV), IMPROVER. Dr Belcastro actively contributed to the organization of the Species Translation challenge, and to the set-up of the Network Verification challenge (https://www.sbvimprover.com/). These activities eventually resulted in the publication of scientific manuscripts in leading journals.Moreover, during his period at PMI, Dr Belcastro led the TOX Portal project, consisting in developing a web platform for toxicological assessment of cellular perturbations. The platform prototype was successfully released before he moved to his next work experience. Show less